News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News New ACC Consensus Document Helps Clinicians Navigate Issues Around TR Todd Neale September 26, 2025
Presentation TCT India 2025 ECMO rounds in ICU - De-escalation, Venting, Trouble shooting Presenter: Venkat Goyal July 26, 2025
News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Daily News Repeat Rejection Still a Problem After Pediatric Heart Transplant Todd Neale October 23, 2024
News Conference News EACTS 2024 In-Hospital Mortality Higher When Female CABG Patients Have Male Surgeons Yael L. Maxwell October 14, 2024
News Conference News EACTS 2024 MACE in CV Trials: Has the Outcome Outlived Its Role? Yael L. Maxwell October 11, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
News Conference News HRS 2024 CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation L.A. McKeown May 23, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Conference News STS 2024 STS Survey Identifies Stark Gender Disparities in Compensation Yael L. Maxwell January 30, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023